Article
Author(s):
Nashville - For the first time, patients with recurrent head and neck tumors have a less invasive alternative to conventional 10- to 12-hour surgery.
Q&A: Amy McMichael, MD, Discusses 48-Week VISIBLE Study Results on Psoriasis in Patients With Skin of Color
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Phase 2b Trial Reinforces Zasocitinib’s Safety Profile
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Journal Digest: October 8
Valisure's David Light Shares Insights Into Newly-Published Benzene and BPO Data